| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.49 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |